Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction

NCT06831149 is registered in ClinicalTrials.gov with Matthew Spector as lead sponsor.

NCT NCT06831149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06831149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction
Lead sponsor
Matthew Spector
Phase
Phase 2
Overall status
Recruiting
Start date
February 28, 2025
Completion date
February 28, 2030
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharyngocutaneous fistula, squamous cell carcinoma